Hod Hasharon, Israel

Naama Lahav

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Incredo Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naama Lahav. Retrieved from https://idiyas.com/inventor/naama-lahav-ghrvolw6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naama Lahav and Sweetener Concentrate Formulations.

Introduction

Naama Lahav is an inventor associated with Hod Hasharon, Israel, and Incredo Ltd. Her patent work concerns sweetener concentrates and formulations for sweetened foods.

Latest Patents

Lahav is associated with 1 patent, titled “Sweetener Concentrate Formulations.” The patent describes sweetener concentrates and food formulations containing particles of a first sweetener and crystalline sugar particles. At least one protein is incorporated within the sweetener particles, with a specified protein-to-sweetener weight ratio. The formulation also requires at least 40% of its total sweetener by weight to be crystalline.

Career Highlights

Lahav’s listed patent reflects work on combining proteins, sweeteners, and crystalline sugar in formulations intended for sweetened food products. Her association with Incredo Ltd. connects this work to the company’s innovation activities.

Collaborations

Lahav’s listed coworkers include David Tsivion and Liron Bitan.

Conclusion

Naama Lahav’s patent activity centers on sweetener concentrate formulations, bringing together protein-containing sweetener particles and crystalline sugar for potential use in sweetened foods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…